Inflammatory neuronal loss in the substantia nigra induced by systemic lipopolysaccharide is prevented by knockout of the P2Y6 receptor in mice

Abstract Inflammation may contribute to multiple brain pathologies. One cause of inflammation is lipopolysaccharide/endotoxin (LPS), the levels of which are elevated in blood and/or brain during bacterial infections, gut dysfunction and neurodegenerative diseases, such as Parkinson’s disease. How in...

Full description

Bibliographic Details
Main Authors: Stefan Milde, Francesca W. van Tartwijk, Anna Vilalta, Tamara C. Hornik, Jacob M. Dundee, Mar Puigdellívol, Guy C. Brown
Format: Article
Language:English
Published: BMC 2021-10-01
Series:Journal of Neuroinflammation
Subjects:
Online Access:https://doi.org/10.1186/s12974-021-02280-2
_version_ 1818937191358791680
author Stefan Milde
Francesca W. van Tartwijk
Anna Vilalta
Tamara C. Hornik
Jacob M. Dundee
Mar Puigdellívol
Guy C. Brown
author_facet Stefan Milde
Francesca W. van Tartwijk
Anna Vilalta
Tamara C. Hornik
Jacob M. Dundee
Mar Puigdellívol
Guy C. Brown
author_sort Stefan Milde
collection DOAJ
description Abstract Inflammation may contribute to multiple brain pathologies. One cause of inflammation is lipopolysaccharide/endotoxin (LPS), the levels of which are elevated in blood and/or brain during bacterial infections, gut dysfunction and neurodegenerative diseases, such as Parkinson’s disease. How inflammation causes neuronal loss is unclear, but one potential mechanism is microglial phagocytosis of neurons, which is dependent on the microglial P2Y6 receptor. We investigated here whether the P2Y6 receptor was required for inflammatory neuronal loss. Intraperitoneal injection of LPS on 4 successive days resulted in specific loss of dopaminergic neurons (measured as cells staining with tyrosine hydroxylase or NeuN) in the substantia nigra of wild-type mice, but no neuronal loss in cortex or hippocampus. This supports the hypothesis that neuronal loss in Parkinson’s disease may be driven by peripheral LPS. By contrast, there was no LPS-induced neuronal loss in P2Y6 receptor knockout mice. In vitro, LPS-induced microglial phagocytosis of cells was prevented by inhibition of the P2Y6 receptor, and LPS-induced neuronal loss was reduced in mixed glial–neuronal cultures from P2Y6 receptor knockout mice. This supports the hypothesis that microglial phagocytosis contributes to inflammatory neuronal loss, and can be prevented by blocking the P2Y6 receptor, suggesting that P2Y6 receptor antagonists might be used to prevent inflammatory neuronal loss in Parkinson’s disease and other brain pathologies involving inflammatory neuronal loss.
first_indexed 2024-12-20T05:48:02Z
format Article
id doaj.art-890f380a8f9344229c6b9ea73e367087
institution Directory Open Access Journal
issn 1742-2094
language English
last_indexed 2024-12-20T05:48:02Z
publishDate 2021-10-01
publisher BMC
record_format Article
series Journal of Neuroinflammation
spelling doaj.art-890f380a8f9344229c6b9ea73e3670872022-12-21T19:51:16ZengBMCJournal of Neuroinflammation1742-20942021-10-011811910.1186/s12974-021-02280-2Inflammatory neuronal loss in the substantia nigra induced by systemic lipopolysaccharide is prevented by knockout of the P2Y6 receptor in miceStefan Milde0Francesca W. van Tartwijk1Anna Vilalta2Tamara C. Hornik3Jacob M. Dundee4Mar Puigdellívol5Guy C. Brown6Department of Biochemistry, University of CambridgeDepartment of Biochemistry, University of CambridgeDepartment of Biochemistry, University of CambridgeDepartment of Biochemistry, University of CambridgeDepartment of Biochemistry, University of CambridgeDepartment of Biochemistry, University of CambridgeDepartment of Biochemistry, University of CambridgeAbstract Inflammation may contribute to multiple brain pathologies. One cause of inflammation is lipopolysaccharide/endotoxin (LPS), the levels of which are elevated in blood and/or brain during bacterial infections, gut dysfunction and neurodegenerative diseases, such as Parkinson’s disease. How inflammation causes neuronal loss is unclear, but one potential mechanism is microglial phagocytosis of neurons, which is dependent on the microglial P2Y6 receptor. We investigated here whether the P2Y6 receptor was required for inflammatory neuronal loss. Intraperitoneal injection of LPS on 4 successive days resulted in specific loss of dopaminergic neurons (measured as cells staining with tyrosine hydroxylase or NeuN) in the substantia nigra of wild-type mice, but no neuronal loss in cortex or hippocampus. This supports the hypothesis that neuronal loss in Parkinson’s disease may be driven by peripheral LPS. By contrast, there was no LPS-induced neuronal loss in P2Y6 receptor knockout mice. In vitro, LPS-induced microglial phagocytosis of cells was prevented by inhibition of the P2Y6 receptor, and LPS-induced neuronal loss was reduced in mixed glial–neuronal cultures from P2Y6 receptor knockout mice. This supports the hypothesis that microglial phagocytosis contributes to inflammatory neuronal loss, and can be prevented by blocking the P2Y6 receptor, suggesting that P2Y6 receptor antagonists might be used to prevent inflammatory neuronal loss in Parkinson’s disease and other brain pathologies involving inflammatory neuronal loss.https://doi.org/10.1186/s12974-021-02280-2MicrogliaPhagocytosisNeuroinflammationCell deathParkinson’s diseaseNeurodegeneration
spellingShingle Stefan Milde
Francesca W. van Tartwijk
Anna Vilalta
Tamara C. Hornik
Jacob M. Dundee
Mar Puigdellívol
Guy C. Brown
Inflammatory neuronal loss in the substantia nigra induced by systemic lipopolysaccharide is prevented by knockout of the P2Y6 receptor in mice
Journal of Neuroinflammation
Microglia
Phagocytosis
Neuroinflammation
Cell death
Parkinson’s disease
Neurodegeneration
title Inflammatory neuronal loss in the substantia nigra induced by systemic lipopolysaccharide is prevented by knockout of the P2Y6 receptor in mice
title_full Inflammatory neuronal loss in the substantia nigra induced by systemic lipopolysaccharide is prevented by knockout of the P2Y6 receptor in mice
title_fullStr Inflammatory neuronal loss in the substantia nigra induced by systemic lipopolysaccharide is prevented by knockout of the P2Y6 receptor in mice
title_full_unstemmed Inflammatory neuronal loss in the substantia nigra induced by systemic lipopolysaccharide is prevented by knockout of the P2Y6 receptor in mice
title_short Inflammatory neuronal loss in the substantia nigra induced by systemic lipopolysaccharide is prevented by knockout of the P2Y6 receptor in mice
title_sort inflammatory neuronal loss in the substantia nigra induced by systemic lipopolysaccharide is prevented by knockout of the p2y6 receptor in mice
topic Microglia
Phagocytosis
Neuroinflammation
Cell death
Parkinson’s disease
Neurodegeneration
url https://doi.org/10.1186/s12974-021-02280-2
work_keys_str_mv AT stefanmilde inflammatoryneuronallossinthesubstantianigrainducedbysystemiclipopolysaccharideispreventedbyknockoutofthep2y6receptorinmice
AT francescawvantartwijk inflammatoryneuronallossinthesubstantianigrainducedbysystemiclipopolysaccharideispreventedbyknockoutofthep2y6receptorinmice
AT annavilalta inflammatoryneuronallossinthesubstantianigrainducedbysystemiclipopolysaccharideispreventedbyknockoutofthep2y6receptorinmice
AT tamarachornik inflammatoryneuronallossinthesubstantianigrainducedbysystemiclipopolysaccharideispreventedbyknockoutofthep2y6receptorinmice
AT jacobmdundee inflammatoryneuronallossinthesubstantianigrainducedbysystemiclipopolysaccharideispreventedbyknockoutofthep2y6receptorinmice
AT marpuigdellivol inflammatoryneuronallossinthesubstantianigrainducedbysystemiclipopolysaccharideispreventedbyknockoutofthep2y6receptorinmice
AT guycbrown inflammatoryneuronallossinthesubstantianigrainducedbysystemiclipopolysaccharideispreventedbyknockoutofthep2y6receptorinmice